# Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes

> **NCT04532346** · EARLY_PHASE1 · RECRUITING · sponsor: **Children's Hospital of Fudan University** · enrollment: 60 (estimated)

## Conditions studied

- Interstitial Lung Disease
- Surfactant Dysfunction

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04532346
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-10
- **Final completion:** 2027-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04532346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04532346, "Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04532346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*